Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C

Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 500-507

  Kobayashi, Koju ^a,b   Ishii, Motoyasu ^a   Igarashi, Takehiko ^a   Satoh, Toshihiro ^c   Miyazaki, Yutaka ^d   Yajima, Yoshiaki ^e   Ukai, Katsuaki ^f   Suzuki, Hiroshi ^d   Kanno, Atushi ^g   Ueno, Yoshiyuki ^a   Miura, Toshihiko ^h   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Sendai Red Cross Hospital   (Japan)

^d TOHOKU ROSAI HOSPITAL   (Japan)

^e SENDAI CITY HOSPITAL   (Japan)

^f Miyagi Cancer Center   (Japan)

^g Tohoku Kouseinenkin Hospital   (Japan)

^h TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; IL 4 producing Th cell; INF producing Th cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY CD3; RECOMBINANT GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD3; ASIAN CONTINENTAL ANCESTRY GROUP; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE;

EID: 7344228420     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050122     Document Type: Article

References (33)

1. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993;104:877-883.
2. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 1994;21:1-3.
3. Rosa F, Fellous M. The effect of gamma-interferon on MHC antigens. Immunol Today 1984;5:261-262.
4. Danis VA, Kulesz AJ, Nelson DS, Brooks PM. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumor necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha. Clin Exp Immunol 1990;80:435-443.
5. Brunda MJ, Tarnowski D, Davatelis V. Interaction of recombinant interferons with recombinant interluekin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cells. Int J Cancer 1986;37:787-793.
6. Battegay M, Moskophidis D, Rahemutulla A, et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cells-definicient mice. J Virol 1994;68:4700-4704.
7. Erickson AL, Houghton M, Choo QL, et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 1993;151:4189-4199.
8. Clerici M, Stocks NI, Zajac RA, et al. Detection of three patterns of T helper cell dysfunction in symptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989;84:1892-1899.
9. Reiss CS, Rouse BT. The current status of viral immunology. Immunol Today 1993;14:333-335.
10. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-348.
11. Racke MK, Bonomo KR, Scott DE, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-1966.
12. Kobayashi K, Ueno Y, Suzuki H, et al. Anti-idiotypic antibody production in hepatitis B vaccine recipients. J Gastroenterol 1994;29:740-744.
13. Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J Exp Med 1993;178:1655-1663.
14. Craxi A, Fiorentino G, Di Marco V, et al. Second-generation tests in diagnosis of chronic hepatitis C. Lancet 1991;337:1354.
15. Saitoh Y, Miura M, Niitsuma H, et al. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration. Tohoku J Exp Med 1994;173:361-369.
16. Kato N, Yokosuka O, Hosoda K, et al. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 1993;18:16-20.
17. Simmons P, Rose KA, Graham S, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV type 1, 2 and 3. J Clin Microbiol 1993;31:1493-1503.
18. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
19. Koup RA. Virus escape from CTL recognition. J Exp Med 1994;180:779-782.
20. Pircher H, Moskophidis D, Rohrer U, et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990;346:629-633.
21. Burgert H-G, Mayanski JL, Kvist S. E3/19K Protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 1987;84:1356-1360.
22. Ahmed R, Stevens JG. Viral persistence. In: Fields BN, Knipe DM (eds) Virology. New York: Raven, 1990;241-265.
23. Tishon A, Borrow P, Evans C, Oldstone MBA. Virus-induced immunesuppression 1: Age at infection relates to a selective or generalized defect. Virology 1993;195:397-405.
24. Cacciarelli TV, Martinez OM, Gish RG, et al. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alpha. Hepatology 1996;24:6-9.
25. Iwata K, Wakita T, Okumura A, et al. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995;22: 1057-1064.
26. Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-1419.
27. Milich DR, Schödel F, Peterson DL, et al. Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 1995;25:1663-1672.
28. Taniguchi S, Okamoto H, Sakamoto M, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology 1993;195:297-301.
29. Bichard P, Ounanian A, Girard M, et al. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol 1994;21:58-63.
30. Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C (HCV)-specific T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993;67:7522-7532.
31. Kita H, Moriyama T, Kaneko T, et al. HLA B44-restricted T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993;18:1039-1044.
32. Ballardini G, Groff P, Pontisso P, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995;95:2067-2075.
33. Koziel MJ, Dudley D, Afdhal N, et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995;96:2311-2321.